18 /100
LOW RISK
Score updated May 28, 2026

RPRX — Royalty Pharma plc Dilution Risk Tracker

Track RPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RPRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for RPRX.
🔔 Track RPRX — Get forecast alerts →

💹 Market Data

Market Cap$31.26B
Shares Outstanding443.27M
Float410.36M
Cash$586.39M
Debt$8.96B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 9.3% shares (2025Q4 vs prior)
535 institutional holders · 375.68M shares
#1 MORGAN STANLEY 55.27M shares
#2 Capital International Investors 31.10M shares
#3 FMR LLC 26.27M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest13.82M
Days to Cover4.4
% of Float3.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 31, 2026
4 INSIDER TRANSACTION Mar 25, 2026
4 INSIDER TRANSACTION Mar 04, 2026
4 INSIDER TRANSACTION Feb 25, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track RPRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RPRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for RPRX
📊 RPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RPRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.